Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Quality of life in the photodermatoses: the hidden toll of photosensitivity.

Walburn J, Sarkany RPE.

Br J Dermatol. 2020 Jan 20. doi: 10.1111/bjd.18804. [Epub ahead of print] No abstract available.

PMID:
31957009
2.

Dramatic response of metastatic cutaneous angiosarcoma to an immune checkpoint inhibitor in a patient with xeroderma pigmentosum: whole-genome sequencing aids treatment decision in end-stage disease.

Momen S, Fassihi H, Davies HR, Nikolaou C, Degasperi A, Stefanato CM, Dias JML, Dasgupta D, Craythorne E, Sarkany R, Papa S, Nik-Zainal S.

Cold Spring Harb Mol Case Stud. 2019 Oct 23;5(5). pii: a004408. doi: 10.1101/mcs.a004408. Print 2019 Oct.

3.

Facial photoprotection in xeroderma pigmentosum (XP) patients: Validation of a new self-reported questionnaire of adherence.

Canfield M, Norton S, Walburn J, Morrison-Bowen N, Sainsbury K, Araujo-Soares V, Sarkany R, Weinman J.

Photodermatol Photoimmunol Photomed. 2020 Mar;36(2):118-125. doi: 10.1111/phpp.12519. Epub 2019 Oct 28.

PMID:
31596975
4.

Evaluation of a personalised adherence intervention to improve photoprotection in adults with Xeroderma Pigmentosum (XP): protocol for the trial of XPAND.

Walburn J, Norton S, Sarkany R, Sainsbury K, Araújo-Soares V, Morgan M, Canfield M, Foster L, Heydenreich J, McCrone P, Mander A, Sniehotta FF, Wulf HC, Weinman J.

BMJ Open. 2019 Jul 17;9(7):e028577. doi: 10.1136/bmjopen-2018-028577.

5.

Psychological correlates of adherence to photoprotection in a rare disease: International survey of people with Xeroderma Pigmentosum.

Walburn J, Canfield M, Norton S, Sainsbury K, Araújo-Soares V, Foster L, Berneburg M, Sarasin A, Morrison-Bowen N, Sniehotta FF, Sarkany R, Weinman J.

Br J Health Psychol. 2019 Sep;24(3):668-686. doi: 10.1111/bjhp.12375. Epub 2019 Jun 10.

6.

Hydroa vacciniforme-like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in whites.

Cohen JI, Manoli I, Dowdell K, Krogmann TA, Tamura D, Radecki P, Bu W, Turk SP, Liepshutz K, Hornung RL, Fassihi H, Sarkany RP, Bonnycastle LL, Chines PS, Swift AJ, Myers TG, Levoska MA, DiGiovanna JJ, Collins FS, Kraemer KH, Pittaluga S, Jaffe ES.

Blood. 2019 Jun 27;133(26):2753-2764. doi: 10.1182/blood.2018893750. Epub 2019 May 7.

PMID:
31064750
7.
8.

Xeroderma pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptoms.

Abeti R, Zeitlberger A, Peelo C, Fassihi H, Sarkany RPE, Lehmann AR, Giunti P.

Br J Pharmacol. 2019 Nov;176(22):4293-4301. doi: 10.1111/bph.14557. Epub 2019 Jan 23. Review.

PMID:
30499105
9.

Understanding and predicting a complex behavior using n-of-1 methods: Photoprotection in xeroderma pigmentosum.

Sainsbury K, Vieira R, Walburn J, Sniehotta FF, Sarkany R, Weinman J, Araujo-Soares V.

Health Psychol. 2018 Dec;37(12):1145-1158. doi: 10.1037/hea0000673. Epub 2018 Sep 17.

PMID:
30221970
10.

The UV/Visible Radiation Boundary Region (385-405 nm) Damages Skin Cells and Induces "dark" Cyclobutane Pyrimidine Dimers in Human Skin in vivo.

Lawrence KP, Douki T, Sarkany RPE, Acker S, Herzog B, Young AR.

Sci Rep. 2018 Aug 24;8(1):12722. doi: 10.1038/s41598-018-30738-6.

11.

Sub-optimal Application of a High SPF Sunscreen Prevents Epidermal DNA Damage in Vivo.

Young AR, Greenaway J, Harrison GI, Lawrence KP, Sarkany R, Douki T, Boyer F, Josse G, Questel E, Monteil C, Rossi AB.

Acta Derm Venereol. 2018 Oct 10;98(9):880-887. doi: 10.2340/00015555-2992.

12.

Diffuse Reflectance Spectroscopy as a Reliable Means of Comparing Ultraviolet Radiation-induced Erythema in Extreme Skin Colors.

Fajuyigbe D, Coleman A, Sarkany RPE, Young AR, Schmalwieser AW.

Photochem Photobiol. 2018 Sep;94(5):1066-1070. doi: 10.1111/php.12947. Epub 2018 Jul 4.

PMID:
29869793
13.

Melanin distribution in human epidermis affords localized protection against DNA photodamage and concurs with skin cancer incidence difference in extreme phototypes.

Fajuyigbe D, Lwin SM, Diffey BL, Baker R, Tobin DJ, Sarkany RPE, Young AR.

FASEB J. 2018 Jul;32(7):3700-3706. doi: 10.1096/fj.201701472R. Epub 2018 Feb 2.

PMID:
29394104
14.

Xeroderma pigmentosum is a definite cause of Huntington's disease-like syndrome.

Garcia-Moreno H, Fassihi H, Sarkany RPE, Phukan J, Warner T, Lehmann AR, Giunti P.

Ann Clin Transl Neurol. 2017 Dec 4;5(1):102-108. doi: 10.1002/acn3.511. eCollection 2018 Jan.

15.

Paediatric solar urticaria: a case series.

Fityan A, McGibbon D, Fassihi H, Sarkany RS.

Br J Dermatol. 2018 Jun;178(6):1453-1454. doi: 10.1111/bjd.16325. Epub 2018 Apr 22. No abstract available.

PMID:
29315482
16.

Chronic actinic dermatitis: successful treatment with psoralen-ultraviolet A photochemotherapy.

Chee SN, Novakovic L, Fassihi H, Garibaldinos T, Sarkany R.

Br J Dermatol. 2018 Mar;178(3):e189-e190. doi: 10.1111/bjd.15969. Epub 2018 Jan 15. No abstract available.

PMID:
28889653
17.

An investigation of the predictors of photoprotection and UVR dose to the face in patients with XP: a protocol using observational mixed methods.

Walburn J, Sarkany R, Norton S, Foster L, Morgan M, Sainsbury K, Araújo-Soares V, Anderson R, Garrood I, Heydenreich J, Sniehotta FF, Vieira R, Wulf HC, Weinman J.

BMJ Open. 2017 Aug 21;7(8):e018364. doi: 10.1136/bmjopen-2017-018364.

18.

Solar urticaria developing in patients with erythropoietic protoporphyria: a clue to the pathogenesis of solar urticaria?

Tewari A, Fityan A, Fassihi H, Sarkany R.

Br J Dermatol. 2018 Feb;178(2):567-568. doi: 10.1111/bjd.15882. Epub 2018 Jan 20. No abstract available.

PMID:
28796891
19.

Photoaggravated contact dermatitis caused by methylisothiazolinone.

Trokoudes D, Banerjee P, Fityan A, Sarkany R, White IR, White JM, McFadden JP.

Contact Dermatitis. 2017 May;76(5):303-304. doi: 10.1111/cod.12718. No abstract available.

PMID:
28386977
20.

Are very high cumulative doses of narrowband UVB safe in vitiligo?

Momen S, Sarkany R.

Photodermatol Photoimmunol Photomed. 2017 Jul;33(4):220-221. doi: 10.1111/phpp.12306. Epub 2017 May 23. No abstract available.

PMID:
28370729
21.

Congenital erythropoietic porphyria: mild presentation with late onset associated with a mutation in the UROS gene promoter sequence.

Fityan A, Fassihi H, Sarkany R.

Clin Exp Dermatol. 2016 Dec;41(8):953-954. doi: 10.1111/ced.12932. No abstract available.

PMID:
27859603
22.

A 'spot' diagnosis.

Sebaratnam DF, Sarkany RPE, Fassihi H.

Arch Dis Child Educ Pract Ed. 2017 Aug;102(4):220-221. doi: 10.1136/archdischild-2016-310555. Epub 2016 Apr 26. No abstract available.

PMID:
27117973
23.

Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect.

Fassihi H, Sethi M, Fawcett H, Wing J, Chandler N, Mohammed S, Craythorne E, Morley AM, Lim R, Turner S, Henshaw T, Garrood I, Giunti P, Hedderly T, Abiona A, Naik H, Harrop G, McGibbon D, Jaspers NG, Botta E, Nardo T, Stefanini M, Young AR, Sarkany RP, Lehmann AR.

Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):E1236-45. doi: 10.1073/pnas.1519444113. Epub 2016 Feb 16.

24.

British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen-ultraviolet A therapy 2015.

Ling TC, Clayton TH, Crawley J, Exton LS, Goulden V, Ibbotson S, McKenna K, Mohd Mustapa MF, Rhodes LE, Sarkany R, Dawe RS.

Br J Dermatol. 2016 Jan;174(1):24-55. doi: 10.1111/bjd.14317. No abstract available.

PMID:
26790656
25.

A Distinct Genotype of XP Complementation Group A: Surprisingly Mild Phenotype Highly Prevalent in Northern India/Pakistan/Afghanistan.

Sethi M, Haque S, Fawcett H, Wing JF, Chandler N, Mohammed S, Frayling IM, Norris PG, McGibbon D, Young AR, Sarkany RPE, Lehmann AR, Fassihi H.

J Invest Dermatol. 2016 Apr;136(4):869-872. doi: 10.1016/j.jid.2015.12.031. Epub 2015 Dec 29. No abstract available.

26.

Topical monobenzyl ether of hydroquinone is an effective and safe treatment for depigmentation of extensive vitiligo in the medium term: a retrospective cohort study of 53 cases.

Tan ES, Sarkany R.

Br J Dermatol. 2015 Jun;172(6):1662-1664. doi: 10.1111/bjd.13642. Epub 2015 Apr 27. No abstract available.

PMID:
25556887
27.

Upregulation of MMP12 and its activity by UVA1 in human skin: potential implications for photoaging.

Tewari A, Grys K, Kollet J, Sarkany R, Young AR.

J Invest Dermatol. 2014 Oct;134(10):2598-2609. doi: 10.1038/jid.2014.173. Epub 2014 Apr 8.

28.

A case of extensive hyaline deposition in facial skin caused by erythropoietic protoporphyria.

Tewari A, Fassihi H, McGibbon D, Robson A, Sarkany R.

Br J Dermatol. 2014 Aug;171(2):412-4. doi: 10.1111/bjd.13034. Epub 2014 Aug 5.

PMID:
24701996
29.

Congenital erythropoietic porphyria: a case in which symptoms were precipitated by an unrelated anaemia.

Verma A, Rashidghamat E, Martinez A, Fassihi H, Sarkany R.

Br J Dermatol. 2014 Aug;171(2):422-3. doi: 10.1111/bjd.12945. Epub 2014 Jul 26. No abstract available.

PMID:
24601890
30.

Measles in a previously vaccinated human immunodeficiency virus-positive adult.

Mahil SK, Fleming J, Robson A, Sarkany R.

Clin Exp Dermatol. 2014 Jan;39(1):117-8. doi: 10.1111/ced.12238. Epub 2013 Nov 7. No abstract available.

PMID:
24341480
31.

Patients with xeroderma pigmentosum complementation groups C, E and V do not have abnormal sunburn reactions.

Sethi M, Lehmann AR, Fawcett H, Stefanini M, Jaspers N, Mullard K, Turner S, Robson A, McGibbon D, Sarkany R, Fassihi H.

Br J Dermatol. 2013 Dec;169(6):1279-87. doi: 10.1111/bjd.12523.

PMID:
23889214
32.

Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia.

Kashiyama K, Nakazawa Y, Pilz DT, Guo C, Shimada M, Sasaki K, Fawcett H, Wing JF, Lewin SO, Carr L, Li TS, Yoshiura K, Utani A, Hirano A, Yamashita S, Greenblatt D, Nardo T, Stefanini M, McGibbon D, Sarkany R, Fassihi H, Takahashi Y, Nagayama Y, Mitsutake N, Lehmann AR, Ogi T.

Am J Hum Genet. 2013 May 2;92(5):807-19. doi: 10.1016/j.ajhg.2013.04.007. Epub 2013 Apr 25.

33.

Photopatch testing: recommendations for a European photopatch test baseline series.

Gonçalo M, Ferguson J, Bonevalle A, Bruynzeel DP, Giménez-Arnau A, Goossens A, Kerr A, Lecha M, Neumann N, Niklasson B, Pigatto P, Rhodes LE, Rustemeyer T, Sarkany R, Thomas P, Wilkinson M.

Contact Dermatitis. 2013 Apr;68(4):239-43. doi: 10.1111/cod.12037. Review.

PMID:
23510344
34.

UVA1 is skin deep: molecular and clinical implications.

Tewari A, Grage MM, Harrison GI, Sarkany R, Young AR.

Photochem Photobiol Sci. 2013 Jan;12(1):95-103. doi: 10.1039/c2pp25323b.

PMID:
23192740
35.

Oral cholestyramine is not an effective treatment for uncomplicated erythropoietic protoporphyria.

Tewari A, Marsden J, Naik H, Benton EC, Sarkany R.

J Am Acad Dermatol. 2012 Dec;67(6):1383-4. doi: 10.1016/j.jaad.2012.02.006. No abstract available.

PMID:
23158617
36.

Determinants of vitamin D status in long-term renal transplant patients.

Penny H, Frame S, Dickinson F, Garrett G, Young AR, Sarkany R, Chitalia N, Hampson G, Goldsmith D.

Clin Transplant. 2012 Nov-Dec;26(6):E617-23. doi: 10.1111/ctr.12039. Epub 2012 Oct 22.

PMID:
23083399
37.

Congenital erythropoietic porphyria: bringing evidence-based practice to a rare disease.

Sarkany R.

Br J Dermatol. 2012 Oct;167(4):709. doi: 10.1111/bjd.12030. No abstract available.

PMID:
23013311
38.

Acute intermittent porphyria: fatal complications of treatment.

Stein PE, Badminton MN, Barth JH, Rees DC, Sarkany R, Stewart MF, Cox TM.

Clin Med (Lond). 2012 Jun;12(3):293-4.

39.

Photopatch testing comes of age.

Sarkany RP.

Br J Dermatol. 2012 May;166(5):912-3. doi: 10.1111/j.1365-2133.2012.10916.x. No abstract available.

PMID:
22524394
40.

A photosensitive pseudolymphomatous eruption. Actinic reticuloid (AR).

Byrne M, Stefanato CM, Sarkany R.

Clin Exp Dermatol. 2012 Mar;37(2):203-4. doi: 10.1111/j.1365-2230.2011.04099.x. No abstract available.

PMID:
22340697
41.

Ultraviolet A1 phototherapy: a British Photodermatology Group workshop report.

Kerr AC, Ferguson J, Attili SK, Beattie PE, Coleman AJ, Dawe RS, Eberlein B, Goulden V, Ibbotson SH, Menage Hdu P, Moseley H, Novakovic L, Walker SL, Woods JA, Young AR, Sarkany RP.

Clin Exp Dermatol. 2012 Apr;37(3):219-26. doi: 10.1111/j.1365-2230.2011.04256.x. Epub 2012 Jan 25. Review.

PMID:
22277060
42.

Human erythema and matrix metalloproteinase-1 mRNA induction, in vivo, share an action spectrum which suggests common chromophores.

Tewari A, Lahmann C, Sarkany R, Bergemann J, Young AR.

Photochem Photobiol Sci. 2012 Jan;11(1):216-23. doi: 10.1039/c1pp05243h. Epub 2011 Nov 14. Erratum in: Photochem Photobiol Sci. 2012 Dec;11(12):1953.

PMID:
22080054
43.

UVA1 induces cyclobutane pyrimidine dimers but not 6-4 photoproducts in human skin in vivo.

Tewari A, Sarkany RP, Young AR.

J Invest Dermatol. 2012 Feb;132(2):394-400. doi: 10.1038/jid.2011.283. Epub 2011 Oct 6.

44.

Successful treatment of microstomia with UVA1 phototherapy in systemic sclerosis.

Tewari A, Garibaldinos T, Lai-Cheong J, Groves R, Sarkany R, Branislav Novakovic L.

Photodermatol Photoimmunol Photomed. 2011 Apr;27(2):113-4. doi: 10.1111/j.1600-0781.2011.00570.x. No abstract available.

PMID:
21392116
45.

Erythropoietic uroporphyria associated with myeloid malignancy is likely distinct from autosomal recessive congenital erythropoietic porphyria.

Sarkany RP, Ibbotson SH, Whatley SD, Lawrence CM, Gover P, Mufti GJ, Murphy GM, Masters GS, Badminton MN, Elder GH.

J Invest Dermatol. 2011 May;131(5):1172-5. doi: 10.1038/jid.2011.5. Epub 2011 Feb 17. No abstract available.

46.

A survey of the optical hazards associated with hospital light sources with reference to the Control of Artificial Optical Radiation at Work Regulations 2010.

Coleman A, Fedele F, Khazova M, Freeman P, Sarkany R.

J Radiol Prot. 2010 Sep;30(3):469-89. doi: 10.1088/0952-4746/30/3/004. Epub 2010 Sep 8.

PMID:
20826885
47.

Erythema gyratum repens associated with pityriasis rubra pilaris.

Almaani N, Robson A, Sarkany R, Griffiths WA.

Clin Exp Dermatol. 2011 Mar;36(2):161-4. doi: 10.1111/j.1365-2230.2010.03861.x.

PMID:
20637029
48.

Photoaggravated Sweet's syndrome.

Natkunarajah J, Gordon K, Chow J, Sarkany R, Millington GW, Marsden RA.

Clin Exp Dermatol. 2010 Apr;35(3):e18-9. doi: 10.1111/j.1365-2230.2009.03329.x. No abstract available.

PMID:
20500161
49.

Clinical implications of advances in understanding the inheritance of erythropoietic protoporphyria.

Sarkany R.

Br J Dermatol. 2010 May;162(5):1156-7. doi: 10.1111/j.1365-2133.2010.09747.x. Epub 2010 Mar 5. No abstract available.

PMID:
20222927
50.

Yellow papules and plaques on the face of a young girl.

Abbott RA, Calonje E, Grattan CE, Kurwa H, Sarkany RP.

Clin Exp Dermatol. 2009 Aug;34(6):745-6. doi: 10.1111/j.1365-2230.2008.02979.x. No abstract available.

PMID:
19635119

Supplemental Content

Loading ...
Support Center